Compromised central tolerance of ICA69 induces multiple organ autoimmunity

Journal of Autoimmunity

Volumn 53, Issue C, 2014, Pages 10-25

  Fan, Yong ^a   Gualtierotti, Giulio ^a   Tajima, Asako ^a   Grupillo, Maria ^a   Coppola, Antonina ^a   He, Jing ^a   Bertera, Suzanne ^a   Owens, Gregory ^a   Pietropaolo, Massimo ^b   Rudert, William A ^a   Trucco, Massimo ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune diabetes; Autoimmune polyendocrine syndrome; Autoimmune thyroiditis; ICA69; Primary Sjogren's syndrome; Thymus

Indexed keywords

AUTOANTIGEN; CELL ANTIGEN; GLUCOSE; ICA69 ANTIGEN; UNCLASSIFIED DRUG; ICA1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENE DELETION; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER HISTOLOGY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; SALIVARY GLAND; SIALOADENITIS; STOMACH; T LYMPHOCYTE; THYMUS; THYROID GLAND; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; INFLAMMATION; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; SALIVARY GLANDS; STOMACH; THYMUS GLAND; THYROID GLAND;

EID: 84926408965     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.07.001     Document Type: Article

References (63)

1. Trucco M. Regeneration of the pancreatic beta cell. JClin Invest 2005, 115:5-12.
2. Narendran P., Estella E., Fourlanos S. Immunology of type 1 diabetes. QJM 2005, 98:547-556.
3. Triolo T.M., Armstrong T.K., McFann K., Yu L., Rewers M.J., Klingensmith G.J., et al. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 2011, 34:1211-1213.
4. Mohn A., Cerruto M., Iafusco D., Prisco F., Tumini S., Stoppoloni O., et al. Celiac disease in children and adolescents with type I diabetes: importance of hypoglycemia. JPediatr Gastroenterol Nutr 2001, 32:37-40.
5. Denzer C., Karges B., Nake A., Rosenbauer J., Schober E., Schwab K.O., et al. Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus. Eur J Endocrinol/Eur Fed Endocr Soc 2013, 168:601-608.
6. Eisenbarth G.S., Gottlieb P.A. Autoimmune polyendocrine syndromes. NEngl J Med 2004, 350:2068-2079.
7. Husebye E.S., Anderson M.S. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity 2010, 32:479-487.
8. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., et al. Positional cloning of the APECED gene. Nat Genet 1997, 17:393-398.
9. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395-1401.
10. Mathis D., Benoist C. Aire Annu Rev Immunol 2009, 27:287-312.
11. Seach N., Ueno T., Fletcher A.L., Lowen T., Mattesich M., Engwerda C.R., et al. The lymphotoxin pathway regulates Aire-independent expression of ectopic genes and chemokines in thymic stromal cells. JImmunol 2008, 180:5384-5392.
12. Kyewski B., Klein L. ACentral role for Central tolerance. Annu Rev Immunol 2006, 24:571-606.
13. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y.L., Martin S., et al. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. JClin Invest 1993, 92:359-371.
14. Miyazaki I., Gaedigk R., Hui M.F., Cheung R.K., Morkowski J., Rajotte R.V., et al. Cloning of human and rat p69 cDNA, a candidate autoimmune target in type 1 diabetes. Biochim Biophys Acta 1994, 1227:101-104.
15. Friday R.P., Pietropaolo S.L., Profozich J., Trucco M., Pietropaolo M. Alternative core promoters regulate tissue-specific transcription from the autoimmune diabetes-related ICA1 (ICA69) gene locus. JBiol Chem 2003, 278:853-863.
16. Lemaire K., Ravier M.A., Schraenen A., Creemers J.W.M., Van de Plas R., Granvik M., et al. Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci 2009, 106:14872-14877.
17. Lieberman S.M., Evans A.M., Han B., Takaki T., Vinnitskaya Y., Caldwell J.A., et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 2003, 100:8384-8388.
18. Eisenbarth G.S., Jackson R.A., Pugliese A. Insulin autoimmunity: the rate limiting factor in pre-type I diabetes. JAutoimmun 1992, (5 Suppl.A):241-246.
19. Cao M., Mao Z., Kam C., Xiao N., Cao X., Shen C., et al. PICK1 and ICA69 control insulin granule trafficking and their deficiencies Lead to impaired glucose tolerance. PLoS Biol 2013, 11:e1001541.
20. Holst B., Madsen K.L., Jansen A.M., Jin C., Rickhag M., Lund V.K., et al. PICK1 deficiency impairs secretory vesicle biogenesis and leads to growth retardation and decreased glucose tolerance. PLoS biol 2013, 11:e1001542.
21. Kyewski B., Peterson P. Aire, master of many trades. Cell 2010, 140:24-26.
22. Mathews C.E., Pietropaolo S.L., Pietropaolo M. Reduced thymic expression of islet antigen contributes to loss of self-tolerance. Ann N Y Acad Sci 2003, 1005:412-417.
23. Bonner S.M., Pietropaolo S.L., Fan Y., Chang Y., Sethupathy P., Morran M.P., et al. Sequence variation in promoter of Ica1 gene, which encodes protein implicated in type 1 diabetes, causes transcription factor autoimmune regulator (AIRE) to increase its binding and down-regulate expression. JBiol Chem 2012, 287:17882-17893.
24. Fan Y., Rudert W.A., Grupillo M., He J., Sisino G., Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J 2009, 28:2812-2824.
25. Song A., Winer S., Tsui H., Sampson A., Pasceri P., Ellis J., et al. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes. Eur J Immunol 2003, 33:546-555.
26. Winer S., Astsaturov I., Cheung R., Tsui H., Song A., Gaedigk R., et al. Primary Sjögren's syndrome and deficiency of ICA69. Lancet 2002, 360:1063-1069.
27. Winer S., Tsui H., Lau A., Song A., Li X., Cheung R.K., et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 2003, 9:198-205.
28. Winer S., Astsaturov I., Gaedigk R., Hammond-McKibben D., Pilon M., Song A., et al. ICA69(null) nonobese diabetic mice develop diabetes, but resist disease acceleration by cyclophosphamide. JImmunol 2002, 168:475-482.
29. Budarf M.L., Goyette P., Boucher G., Lian J., Graham R.R., Claudio J.O., et al. Atargeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 2011, 12:51-58.
30. Fan Y., Menon R.K., Cohen P., Hwang D., Clemens T., DiGirolamo D.J., et al. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. JBiol Chem 2009, 284:19937-19944.
31. Roescher N., Lodde B.M., Vosters J.L., Tak P.P., Catalan M.A., Illei G.G., et al. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjogren's syndrome. Oral Dis 2012, 18:96-106.
32. Greenspan J.S., Daniels T.E., Talal N., Sylvester R.A. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974, 37:217-229.
33. Helmberg W. Bioinformatic databases and resources in the public domain to aid HLA research. Tissue Antigens 2012, 80:295-304.
34. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219.
35. Lee I.F., Qin H., Trudeau J., Dutz J., Tan R. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. JImmunol 2004, 172:937-942.
36. Pilon M., Peng X.R., Spence A.M., Plasterk R.H., Dosch H.M. The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretion. Mol Biol Cell 2000, 11:3277-3288.
37. Lodde B.M., Mineshiba F., Kok M.R., Wang J., Zheng C., Schmidt M., et al. NOD mouse model for Sjogren's syndrome: lack of longitudinal stability. Oral Dis 2006, 12:566-572.
38. Jonsson M.V., Delaleu N., Brokstad K.A., Berggreen E., Skarstein K. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum 2006, 54:2300-2305.
39. Robinson C.P., Yamachika S., Bounous D.I., Brayer J., Jonsson R., Holmdahl R., et al. Anovel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum 1998, 41:150-156.
40. Chentoufi A.A., Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002, 51:1383-1390.
41. Mannisto T., Vaarasmaki M., Pouta A., Hartikainen A.L., Ruokonen A., Surcel H.M., et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. JClin Endocrinol Metab 2010, 95:1084-1094.
42. Martin A.P., Marinkovic T., Canasto-Chibuque C., Latif R., Unkeless J.C., Davies T.F., et al. CCR7 deficiency in NOD mice leads to thyroiditis and primary hypothyroidism. JImmunol 2009, 183:3073-3080.
43. Yu L., Boulware D.C., Beam C.A., Hutton J.C., Wenzlau J.M., Greenbaum C.J., et al. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 2012, 35:1213-1218.
44. Steck A.K., Johnson K., Barriga K.J., Miao D., Yu L., Hutton J.C., et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 2011, 34:1397-1399.
45. Pietropaolo M., Yu S., Libman I.M., Pietropaolo S.L., Riley K., LaPorte R.E., et al. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes 2005, 6:184-192.
46. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996, 45:926-933.
47. Grupillo M., Gualtierotti G., He J., Sisino G., Bottino R., Rudert W.A., et al. Essential roles of insulin expression in Aire+ tolerogenic dendritic cells in maintaining peripheral self-tolerance of islet beta-cells. Cell Immunol 2012, 273:115-123.
48. Scaglia L., Cahill C.J., Finegood D.T., Bonner-Weir S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 1997, 138:1736-1741.
49. Trudeau J.D., Dutz J.P., Arany E., Hill D.J., Fieldus W.E., Finegood D.T. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?. Diabetes 2000, 49:1-7.
50. Monteiro J.P., Farache J., Mercadante A.C., Mignaco J.A., Bonamino M., Bonomo A. Pathogenic effector T cell enrichment overcomes regulatory T cell control and generates autoimmune gastritis. JImmunol 2008, 181:5895-5903.
51. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
52. Winer S., Gunaratnam L., Astsatourov I., Cheung R.K., Kubiak V., Karges W., et al. Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes. JImmunol 2000, 165:4086-4094.
53. Karges W., Gaedigk R., Hui M.F., Cheung R., Dosch H.M. Molecular cloning of murine ICA69: diabetes-prone mice recognize the human autoimmune-epitope, Tep69, conserved in splice variants from both species. Biochim Biophys Acta 1997, 1360:97-101.
54. Pietropaolo M., Towns R., Eisenbarth G.S. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med 2012, 2.
55. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. JAutoimmun 2011, 37:88-94.
56. Dittmar M., Kahaly G.J. Genetics of the autoimmune polyglandular syndrome type 3 variant. Thyroid 2010, 20:737-743.
57. Kyewski B., Derbinski J., Gotter J., Klein L. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol 2002, 23:364-371.
58. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K., et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007, 8:351-358.
59. Michels A.W., Eisenbarth G.S. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2). JIntern Med 2009, 265:530-540.
60. de Graaff L.C., Martin-Martorell P., Baan J., Ballieux B., Smit J.W., Radder J.K. Long-term follow-up of organ-specific antibodies and related organ dysfunction in type 1 diabetes mellitus. Neth J Med 2011, 69:66-71.
61. Velkoska Nakova V., Krstevska B., Dimitrovski C., Simeonova S., Hadzi-Lega M., Serafimoski V. Prevalence of thyroid dysfunction and autoimmunity in pregnant women with gestational diabetes and diabetes type 1. Prilozi 2010, 31:51-59.
62. Morahan G., Mehta M., James I., Chen W.M., Akolkar B., Erlich H.A., et al. Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected Sib-pairs. Diabetes 2011, 60:1030-1040.
63. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.